https://www.taxtmi.com/news?id=72557 Approval has been granted for the manufacture and export of a Class D in-vitro diagnostic HIV 1&2 self-test under the Medical Devices Rules, 2017. The product is designed for private use and uses rapid lateral flow immunoassay technology with a finger-prick blood sample to detect HIV-1 and HIV-2 antibodies without laboratory infrastructure. The approval is for export markets only and is not intended for domestic commercial distribution in India. en-us Tue, 28 Apr 2026 17:01:05 +0530 Tue, 28 Apr 2026 17:01:05 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=72557 Approval has been granted for the manufacture and export of a Class D in-vitro diagnostic HIV 1&2 self-test under the Medical Devices Rules, 2017. The product is designed for private use and uses rapid lateral flow immunoassay technology with a finger-prick blood sample to detect HIV-1 and HIV-2 antibodies without laboratory infrastructure. The approval is for export markets only and is not intended for domestic commercial distribution in India. News - Tue, 28 Apr 2026 17:01:05 +0530 https://www.taxtmi.com/news?id=72557